Ratchaphruek Hospital PCL (BKK:RPH)
Thailand · Delayed Price · Currency is THB 4.880
0.00 (0.00%)
Jun 12, 2026, 4:36 PM ICT
Ratchaphruek Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,147 | 1,162 | 1,125 | 1,161 | 1,326 | 1,413 | |
Revenue Growth (YoY) | 0.98% | 3.27% | -3.05% | -12.49% | -6.12% | 76.72% |
Cost of Revenue | 772 | 771.53 | 751.44 | 750.58 | 827.01 | 746.98 |
Gross Profit | 374.7 | 390.47 | 373.73 | 410.01 | 499.17 | 665.58 |
Selling, General & Admin | 187.3 | 184.67 | 181.22 | 191.46 | 149.5 | 167.72 |
Other Operating Expenses | -21.1 | -21.6 | -17.85 | - | - | - |
Operating Expenses | 166.21 | 163.07 | 163.36 | 191.46 | 149.5 | 167.72 |
Operating Income | 208.49 | 227.41 | 210.37 | 218.55 | 349.67 | 497.86 |
Interest Expense | -0.47 | -0.51 | -0.57 | -2.11 | -5.55 | -6.69 |
Interest & Investment Income | 4.14 | 4.14 | 6.58 | 2.78 | 0.81 | 0.35 |
Other Non Operating Income (Expenses) | - | - | - | 14.16 | 13.26 | 11.54 |
EBT Excluding Unusual Items | 212.16 | 231.03 | 216.37 | 233.38 | 358.19 | 503.07 |
Pretax Income | 212.16 | 231.03 | 216.37 | 233.38 | 358.19 | 503.07 |
Income Tax Expense | 43.97 | 48.66 | 43.84 | 48.92 | 71.73 | 100.07 |
Net Income | 168.19 | 182.37 | 172.53 | 184.45 | 286.47 | 402.99 |
Net Income to Common | 168.19 | 182.37 | 172.53 | 184.45 | 286.47 | 402.99 |
Net Income Growth | -5.10% | 5.70% | -6.46% | -35.61% | -28.92% | 329.43% |
Shares Outstanding (Basic) | 529 | 533 | 546 | 546 | 546 | 546 |
Shares Outstanding (Diluted) | 529 | 533 | 546 | 546 | 546 | 546 |
Shares Change (YoY) | -3.04% | -2.33% | -0.01% | - | - | - |
EPS (Basic) | 0.32 | 0.34 | 0.32 | 0.34 | 0.52 | 0.74 |
EPS (Diluted) | 0.32 | 0.34 | 0.32 | 0.34 | 0.52 | 0.74 |
EPS Growth | -2.12% | 8.22% | -6.46% | -35.61% | -28.92% | 329.43% |
Free Cash Flow | 116.06 | 164.69 | 230.62 | 342.38 | 420.32 | 271.25 |
Free Cash Flow Per Share | 0.22 | 0.31 | 0.42 | 0.63 | 0.77 | 0.50 |
Dividend Per Share | 0.280 | 0.280 | 0.290 | 0.300 | 0.350 | 0.300 |
Dividend Growth | -3.45% | -3.45% | -3.33% | -14.29% | 16.67% | 130.77% |
Gross Margin | 32.68% | 33.60% | 33.22% | 35.33% | 37.64% | 47.12% |
Operating Margin | 18.18% | 19.57% | 18.70% | 18.83% | 26.37% | 35.24% |
Profit Margin | 14.67% | 15.70% | 15.33% | 15.89% | 21.60% | 28.53% |
Free Cash Flow Margin | 10.12% | 14.17% | 20.50% | 29.50% | 31.69% | 19.20% |
EBITDA | 283.31 | 302.14 | 284.77 | 303.46 | 440.29 | 584.49 |
EBITDA Margin | 24.71% | 26.00% | 25.31% | 26.15% | 33.20% | 41.38% |
D&A For EBITDA | 74.81 | 74.73 | 74.4 | 84.91 | 90.62 | 86.62 |
EBIT | 208.49 | 227.41 | 210.37 | 218.55 | 349.67 | 497.86 |
EBIT Margin | 18.18% | 19.57% | 18.70% | 18.83% | 26.37% | 35.24% |
Effective Tax Rate | 20.72% | 21.06% | 20.26% | 20.96% | 20.02% | 19.89% |